Ent Wick Ent Wick

HarioPulse

A new electronic hair loss treatment that
overcomes the limitations of
conventional devices

Contact Us

The Era of 10 Million Hair Loss Patients in Korea

Due to modern stress, genetic factors, and various other causes, alopecia (hair loss) is occurring across a wide range of age groups. While hair loss does not cause pain or directly affect daily life, it can lower confidence and self-esteem, leading to depression. Consequently, the number of individuals seeking active treatment is steadily increasing.

The most active treatment-seeking age groups are in their 30s, followed by those in their 20s and 40s. By gender, 56% of these individuals are men, while 44% are women. Notably, the proportion of women actively seeking treatment has been rapidly increasing recently.

Entwick's Differentiated Hair Loss Treatment Device: HairoPulse

Conventional oral hair loss treatments inhibit dihydrotestosterone (DHT) to delay the hair growth cycle from the growth phase to the resting phase. Due to its chemical mechanism of action, numerous side effects have been reported. Particularly, in women of childbearing age, severe side effects such as birth defects necessitate strict usage guidelines for treating female alopecia.

이미지 제공 예정

Entwick's hair loss treatment device, HairoPulse, activates human dermal papilla cells (Hdpc) in the hair follicle papilla, increasing hair growth factors (Collagen IV, Laminin, ALP, Versican). As a result, the hair growth cycle, hair size, and number of hairs increase, leading to a fuller scalp. This non-invasive treatment method is free from side effects, making it safe for use even in women of childbearing age.

The hair loss treatment mechanism of HarioPulse

  • ELF-EMFVery low frequency electromagnetic fields

  • LLL Low Power Lazer(650nm)

  • Safety Features Wearable Sensor

  • Built-in Battery

  • USBType C Charging

  • Voice guidance features